Portal de recerca
GLIOMA DE BAJO GRADO CON MUTACIONES EN IDH Y 1P/19Q INTACTO TRAS LA RESECCIÓN: ¿ESPERAR O TRATAR? IWOT: ESTUDIO EN FASE III.
Dades bàsiques
- Protocol:
- 1635-BTG
- EURDRACT:
- 2018-003539-31
- NCT:
- Centre:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Any inici:
- 2020
- Any de finalització:
- 2021
Documents
- No hi ha documents
Participants
Grups d'Investigació
Finançadors - Promotors
Resultats de l'Assaig Clínic
[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence
Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda
Editorial Material. 10.1016/j.farma.2024.08.009. 2024
[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Andrés JLP, Solsona MDE
Article. 10.1016/j.farma.2023.10.004. 2024
[Translated article] New challenges in advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2024.05.001. 2024
[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.
Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.12.007. 2025
[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.
Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.09.006. 2024
100% peer review in radiation oncology. Is it feasible?
Martin, E.; (...); Conde, A.
Meeting Abstract. 2020
100% Peer Review in Radiation Oncology. Is it feasible?
Martin Garcia, E.; (...); Tormo, A.
Meeting Abstract. 2021
100% peer review in radiation oncology: is it feasible?
Martin-Garcia E; (...); Conde-Moreno AJ
Review. 10.1007/s12094-020-02394-8. 2020
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma (Dec, 10.1007/s11060-023-04513-1, 2023)
Gately L; (...); Balana C
Correction. 10.1007/s11060-024-04581-x. 2024
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
Gately, L.; (...); Balana, C.
Article. 10.1007/s11060-023-04513-1. 2023
A COMBINED ANALYSIS OF TWO RANDOMISED STUDIES EXPLORING THE IMPACT OF EXTENDED POST-RADIATION TEMOZOLOMIDE ON SURVIVAL OUTCOMES IN NEWLY DIAGNOSED GLIOBLASTOMA
Gately, Lucy; (...); Balana, Carmen
Meeting Abstract. 2023
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain
Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro
Article. 10.33393/grhta.2022.2333. 2022
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.
Zozaya, Neboa; (...); Verde, Luis
Article. 10.1017/S0266462322000459. 2022
A New and Easy-to-Use Survival Score for Patients Irradiated for Metastatic Epidural Spinal Cord Compression.
Rades, Dirk; (...); Schild, Steven E.
Article. 10.1016/j.prro.2022.03.012. 2022
A New Clinical Instrument for Estimating the Ambulatory Status after Irradiation for Malignant Spinal Cord Compression
Rades, Dirk; (...); Schild, Steven E.
Article. 10.3390/cancers14153827. 2022
A Phase II Trial of Stereotactic Body Radiation Therapy and Androgen Deprivation for Oligometastases in Prostate Cancer (SBRT-SG 05).
Conde-Moreno, Antonio J; (...); Ferrer, Carlos
Article. 10.1016/j.prro.2024.04.022. 2024
A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24.
González-San Segundo C; (...); Couñago F
Article. 10.1111/bju.16484. 2024
A Smart Digital Health Platform to Enable Monitoring of Quality of Life and Frailty in Older Patients with Cancer: A Mixed-Methods, Feasibility Study Protocol.
Papachristou, Nikolaos; (...); Bamidis, Panagiotis D.
Article. 10.1016/j.soncn.2023.151437. 2023
Acute and sustained endothelial damage in COVID-19
Mendez, Raul; (...); Menendez, Rosario
Meeting Abstract. 10.1183/13993003.congress-2021.OA3966. 2021
Acute and sustained increase in endothelial biomarkers in COVID-19.
Méndez R; (...); Menéndez R
Article. 10.1136/thoraxjnl-2020-216797. 2021
Addressing the challenges of cancer care in older adults: The unique benefits of oncogeriatric evaluation and management.
Martinez-Peromingo, Javier; (...); Girones, Regina
Letter. 10.1016/j.regg.2023.03.002. 2023
Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting
Garrido Siles, Marga; (...); Angel Climent, Miguel
Review. 10.3390/cancers14163968. 2022
Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR).
Valero J; (...); Millan V
Article. 10.1007/s12094-019-02274-w. 2020
Alveolar capillary dysplasia with misalignment of the pulmonary veins: A surgical lung biopsy and autopsy in a full-term newborn.
Rodríguez García C; (...); Mancheño Franch N
Article. 10.1016/j.patol.2024.06.005. 2024
Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/10781552211038518. 2021
Anti-endotoxin antibodies consumption in cardiovascular collapse: Pathophysiological concerns.
Villarreal, E.; (...); Vila, J.
Article. 10.1016/j.medine.2022.04.019. 2022
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).
Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ
Letter. 10.1111/jdv.19432. 2023
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
BCAS1 defines a heterogeneous cell population in diffuse gliomas.
Morales-Gallel, Raquel; (...); Garcia-Verdugo, Jose Manuel
Article. 10.18632/oncotarget.28553. 2024
Beyond IDH1 R132H mutation-Clinicopathological characteristics of non-canonical IDH mutant gliomas
Martinez-Saez, E.; (...); Toldos-Gonzalez, O.
Meeting Abstract. 2023
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.
Fernandez Rivera C; (...); Hernandez D
Article. 10.1111/ctr.14550. 2022
Biological significance of cribriform pattern in radical prostatectomy specimens: Study of its prognostic significance in biochemical recurrence
Gomez, PF; (...); Boronat, TF
Meeting Abstract. 2021
Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro.
Article. 10.3389/fimmu.2023.1171065. 2023
Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial.
Garcia-Del-Muro, Xavier; (...); Alemany, Ramon
Article. 10.1158/1078-0432.CCR-24-2636. 2025
Cardiovascular Events during and after Bronchiectasis Exacerbations and Long-Term Mortality.
Méndez R; (...); Menéndez R
Article. 10.1016/j.chest.2021.10.013. 2021
Clinical and genetic characteristics of 21 Spanish patients with biallelic pathogenic SPG7 mutations.
Baviera-Muñoz R; (...); Espinós C
Article. 10.1016/j.jns.2021.118062. 2021
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2021.07.009. 2021
Clinical features, mutation spectrum and factors related to reaching molecular diagnosis in a cohort of patients with distal myopathies.
Muelas, Nuria; (...); Vilchez, Juan J
Article. 10.1007/s00415-024-12821-3. 2025
Cold loop polypectomy perforation of a tiny colon polyp.
Mínguez Sabater A; (...); Bustamante-Balén M
Article. 10.17235/reed.2021.8221/2021. 2021
Comparison of 5 x 5 Gy and 10 x 3 Gy for metastatic spinal cord compression using data from three prospective trials
Rades, D; (...); Schild, SE
Article. 10.1186/s13014-020-01737-7. 2021
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano JB; (...); Soto-Ortega I
Article. 10.1016/j.farma.2023.01.003. 2023
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada
Article. 10.1016/j.farma.2023.04.002. 2023
Correction: Update on the management of elderly patients with colorectal cancer.
Soler-González G; (...); Gironés-Sarrió R
Correction. 10.1007/s12094-023-03351-x. 2024
COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN
Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.
Meeting Abstract. 2024
Costs of the management of hemophilia A with inhibitors in Spain
Bonanad, S; (...); Gonzalez-Dominguez, A
Article. 10.33393/grhta.2021.2234. 2021
Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.
Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL
Editorial Material. 10.1016/j.farma.2024.08.001. 2024
Deciphering Multiple Sclerosis Progression.
Meca-Lallana, Virginia; (...); Perez-Miralles, Francisco Carlos
Review. 10.3389/fneur.2021.608491. 2021
Deep learning automatic semantic segmentation of glioblastoma multiforme regions on multimodal magnetic resonance images.
Beser-Robles, Maria; (...); Marti-Bonmati, Luis
Article. 10.1007/s11548-024-03205-z. 2024
Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.
Salinas P; (...); Escaned J
Article. 10.1016/j.carrev.2021.11.015. 2021
Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.
Abad, Maria Reyes; (...); Gil, Alicia
Article. 10.33393/grhta.2024.3041. 2024
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis
Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther
Article. 10.1002/jvc2.275. 2024
Development and Validation of an Early Mortality Risk Score for Older Patients Treated with Chemotherapy for Cancer
Feliu, J; (...); Molina-Garrido, MJ
Article. 10.3390/jcm10081615. 2021
Diagnosis of intraamniotic inflammation by measuring vaginal interleukin-6 in patients with cervical insufficiency: could amniocentesis be avoided?
Diago Muñoz DM; (...); Diago Almela, Vicente Jose
Article. 10.1080/14767058.2022.2029838. 2022
Diagnostic Efficacy of Genetic Studies in a Series of Hereditary Cerebellar Ataxias in Eastern Spain.
Baviera-Munoz, Raquel; (...); Aller, Elena
Article. 10.1212/NXG.0000000000200038. 2022
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment
Palanques-Pastor T; (...); Poveda Andrés JL
Article. 10.1159/000517813. 2021
Elderly glioblastoma patients: Survival analysis according adjuvant therapy and tumor molecular analysis.
Angeles Vaz, Maria; (...); De Las Penas Bataller, Ramon
Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.e14046. 2021
Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study).
Marquez-Rodas, Ivan; (...); Berrocal, Alfonso
Article. 10.1093/neuonc/noae116. 2024
Endothelial Biomarkers Are Superior to Classic Inflammatory Biomarkers in Community-Acquired Pneumonia.
González-Jiménez P; (...); Méndez R
Article. 10.3390/biomedicines12102413. 2024
Endothelial Damage, Neutrophil Extracellular Traps and Platelet Activation in COVID-19 vs. Community-Acquired Pneumonia: A Case-Control Study.
González-Jiménez P; (...); Menéndez R
Article. 10.3390/ijms241713194. 2023
Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization.
Giner Moreno E; (...); Ramos Soler D
Article. 10.3791/65635. 2023
Ensembles of endothelial and mural cells promote angiogenesis in prenatal human brain
Crouch, Elizabeth E.; (...); Huang, Eric J.
Article. 10.1016/j.cell.2022.09.004. 2022
Epidemiology of ataxia and hereditary spastic paraplegia in Spain: A cross-sectional study.
Ortega Suero, G; (...); Sobrido Gomez, M J
Article. 10.1016/j.nrleng.2023.04.003. 2023
Evaluation of EMBARK criteria patients. Real-world data on prostate cancer biochemical recurrence
Centelles Hidalgo, Elena; (...); Lopez-Campos, Fernando
Meeting Abstract. 2024
Experience of GEINO (Spanish cooperative group for research in neuro-oncology) oncologists in the management of adult medulloblastoma
Villar, MV; (...); Santos, JD
Meeting Abstract. 10.1016/j.annonc.2021.08.008. 2021
Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer.
Nadal E; (...); Gironés R
Article. 10.1007/s12094-023-03286-3. 2023
Expert consensus to optimize the treatment of elderly patients with luminal metastatic breast cancer.
Torregrosa-Maicas MD; (...); Gironés-Sarrió R
Article. 10.1007/s12094-021-02766-8. 2022
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).
Gately L; (...); Balana C
Article. 10.1007/s11060-024-04668-5. 2024
Extra-Skeletal Osteosarcoma of the Prostate After Treated Prostatic Acinar Adenocarcinoma: A Case Report and Review of the Literature.
García CR; (...); Segura FG
Article. 10.1177/10668969241283735. 2024
Feasibility and potential advantages using VMAT in SRS metastasis treatments
Jose Perez-Calatayud, Maria; (...); Perez-Calatayud J
Article. 10.5603/RPOR.a2021.0019. 2021
Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report
Fernandez-Sanchez, M; (...); Poveda-Andres, JL
Article. 10.1002/bdr2.1942. 2021
Final database lock results of the phase 2 cohort of lenvatinib plus pembrolizumab for progressive disease after a PD-1/PD-L1-containing therapy in metastatic clear cell renal cell carcinoma
Lee, Chung-Han; (...); Motzer, Robert J.
Meeting Abstract. 2023
Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.
Plaza J; (...); Moret-Tatay I
Article. 10.3390/ijms25073717. 2024
Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
Vaz, M. A.; (...); Girones, R.
Meeting Abstract. 10.1016/j.annonc.2023.09.1695. 2023
Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis
Editorial Material. 2022
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
Solana-Altabella, Antonio; (...); Martinez-Cuadron, David
Article. 10.3390/cancers14081921. 2022
Hereditary Spastic Paraplegia 7 Presenting as Multifocal Dystonia with Prominent Cranio-Cervical Involvement
Campins-Romeu, M; (...); Martinez-Torres, I
Letter. 10.1002/mdc3.13257. 2021
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.
El-Qutob D; (...); Carrera-Hueso FJ
Article. 10.1016/j.hrtlng.2022.02.003. 2022
Higher-dose radiotherapy for metastatic spinal cord compression: First results of a phase II trial
Rades, D.; (...); Cacicedo, J.
Meeting Abstract. 2021
Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies
Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo
Article. 10.7399/fh.11729. 2022
Hospitalization budget impact during the COVID-19 pandemic in Spain.
Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.
Article. 10.1186/s13561-021-00340-0. 2021
How can artificial intelligence optimize value-based contracting?
Poveda, Jose Luis; (...); Medrano, Ignacio H.
Letter. 10.1186/s40545-022-00475-3. 2022
Imaging Biomarkers in Amyotrophic Lateral Sclerosis
Cerda Alberich, Leonor; (...); Marti-Bonmati, Luis
Editorial Material. 10.1007/978-1-0716-1712-0_20. 2022
Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions.
Lopez-Campos, Fernando; (...); Couñago F
Article. 10.3390/biomedicines10030537. 2022
Impact of 68 Ga-PSMA PET/CT in the treatment of prostate cancer: Initial experience in Spain.
Couñago F; (...); Cerro ED
Article. 10.1016/j.rpor.2020.03.024. 2020
Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: a multicenter prospective study.
Rondan, Maria Arnal; (...); Sarrio, Regina Girones
Article. 10.1007/s12094-024-03657-4. 2024
Impact of real-time, dose-escalated permanent seed implant brachytherapy in intermediate-risk prostate cancer
Pons-Llanas, O; (...); Lopez-Torrecilla, J
Article. 10.1016/j.rpor.2020.04.014. 2020
Impact of surgery versus other treatment options in recurrent glioblastoma. Analysis of the Spanish Group of Neurooncology Research (GEINO) RETSINE database.
Vaz Salgado, Maria Angeles; (...); De Las Penas Bataller, Ramon
Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.e14047. 2021
Implementation and comprehensive management of a colletion of fetal brain samples obtained from volunteer termination of pregnancies
Marin Reina, Purificacion; (...); Vento Torres, Maximo
Meeting Abstract. 2022
Initial and Residual Cardiovascular Damage Remaining at Day 30 in Community-acquired Pneumonia
Ocana, R. Mendez; (...); Menendez, R.
Meeting Abstract. https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6241. 2024
Internal dose-escalation with FFF-VMAT and advantages in SRS metastasis treatments
Perez Calatayud, M. J.; (...); Tormo, A.
Meeting Abstract. 2020
Intracranial activity of encorafenib and binimetinib followed by radiotherapy in patients with BRAF mutated melanoma and brain metastasis: Preliminary results of the GEM1802/EBRAIN-MEL phase II clinical trial
Marquez-Rodas, I; (...); Berrocal, A
Meeting Abstract. 10.1016/j.annonc.2021.08.1423. 2021
Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.
Pozo-Rosich P; (...); Irimia P
Article. 10.1186/s10194-024-01747-w. 2024
Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula
Article. 10.3390/antibiotics13080706. 2024
Labyrinthine Bifurcation of the Facial Nerve
Saro-Buendia, Miguel; (...); Carceller, Miguel Armengot
Article. 10.1007/s12070-023-03977-x. 2023
Late-onset vascular complications of radiotherapy for primary brain tumors: a case-control and cross-sectional analysis.
Ibanez-Julia, Maria-Jose; (...); Ricard, Damien
Article. 10.1007/s11764-023-01350-z. 2023
LATTICE radiotherapy: A one institution experience
Solero, I.; (...); Conde, A.
Meeting Abstract. 2023
Leave no one behind: A global survey of the current state of geriatric oncology practice by SIOG national representatives.
Mizutani, Tomonori; (...); Kanesvaran, Ravindran
Article. 10.1016/j.jgo.2024.101709. 2024
Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.
Lee, Chung-Han; (...); Motzer, Robert J
Letter. 10.1016/j.eururo.2024.05.003. 2024
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
Lee, CH; (...); Motzer, JR
Article. 10.1016/S1470-2045(21)00241-2. 2021
Local detection of microvessels in IDH-wildtype glioblastoma using relative cerebral blood volume: an imaging marker useful for astrocytoma grade 4 classification.
Álvarez-Torres MDM; (...); Garcia-Gomez, Juan Miguel
Article. 10.1186/s12885-021-09117-4. 2022
Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.
Megías-Vericat JE; (...); Poveda-Andrés JL
Article. 2021
Management of Patients with Metastatic Bladder Cancer in the Real-World Setting from the Multidisciplinary Team: Current Opinion of the SOGUG Multidisciplinary Working Group.
Gonzalez-del-Alba, Aranzazu; (...); Climent, Miguel Angel
Article. 10.3390/cancers14051130. 2022
Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.
Vázquez Polo A; (...); Vázquez Costa JF
Article. 10.20960/nh.03946. 2022
Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A
Bonanad, S; (...); Santos, S
Article. 10.1007/s12325-021-01853-0. 2021
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Article. 10.3390/cancers14030596. 2022
Metastatic hormone-sensitive prostate cancer: How should it be treated?
López-Campos F; (...); Couñago F
Article. 10.5306/wjco.v12.i2.43. 2021
Multi-Institutional Analysis of Metastasis Directed Therapy with or without Androgen Deprivation Therapy in Oligometastatic Castration Sensitive Prostate Cancer.
Sutera, P.; (...); Sweeney, C.
Article. 10.1016/j.ijrobp.2023.06.1620. 2023
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.
Deek MP; (...); Sweeney C
Article. 10.1016/j.euo.2024.03.010. 2024
Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
Gomez-Cebrian, N; (...); Pineda-Lucena, A
Review. 10.3390/cancers13184544. 2021
National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)
Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel
Correction. 10.7399/fh.11740. 2021
National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies
Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis
Meeting Abstract. 10.1182/blood-2022-169938. 2022
Nests of dividing neuroblasts sustain interneuron production for the developing human brain.
Paredes, Mercedes F.; (...); Huang, Eric J.
Article. 10.1126/science.abk2346. 2022
Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies.
Armangue, Thais; (...); Dalmau, Josep
Article. 10.1093/brain/awad238. 2023
Neutrophil Extracellular Traps and Platelet Activation for Identifying Severe Episodes and Clinical Trajectories in COVID-19
González-Jiménez P; (...); Menéndez R
Article. 10.3390/ijms24076690. 2023
New challenges of advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2023.11.008. 2024
Node Oligorecurrence in Prostate Cancer: A Challenge.
Zapatero A; (...); Aldave D
Article. 10.3390/cancers15164159. 2023
Normal development of cerebellar vermis in midgestation-A roadmap for pathological diagnosis
Ferrer-Lozano, J.; (...); Llorens-Salvador, R.
Meeting Abstract. 2023
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.
Poveda JL; (...); Badia X
Article. 10.1186/s13023-022-02610-4. 2023
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial.
Achard V; (...); Zilli T
Article. 10.1016/j.radonc.2022.04.020. 2022
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Review. 10.3390/biology12091159. 2023
OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT
Flores-Moreno, S.; (...); Gil, A.
Meeting Abstract. 2024
P25.03.B RWD OF IDH MUTANT GLIOMAS IN SPAIN, A RETSINE - GEINO STUDY
Mazariegos, M.; (...); Pineda, E.
Meeting Abstract. 10.1093/neuonc/noae144.446. 2024
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Correction. 10.3389/fped.2021.834454. 2022
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project
Morillo-Verdugo, R; (...); Diaz-Olmo, J
Article. 10.7399/fh.11719. 2021
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.
Morillo-Verdugo R; (...); Díaz-Olmo J
Article. 2021
PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial.
De Bruycker A; (...); Ost P
Article. 10.1186/s12885-020-06911-4. 2020
PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute toxicity of a randomized phase II trial
Ost, P.; (...); Zilli, T.
Meeting Abstract. 2022
PEACE V - STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity
Zilli, T.; (...); Ost, P.
Meeting Abstract. 2022
PEACE V-Salvage Treatment of oligorecurrent nodal prostate cancer metastases (STORM): 24-months toxicity results of a randomized phase II trial
Zilli, T.; (...); Ost, P.
Meeting Abstract. 2024
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial.
Ost, Piet; (...); Zilli, Thomas
Article. 10.1016/j.euo.2023.09.007. 2023
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.
Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis
Article. 10.3390/ijms26041760. 2025
Pharmacometabolomics by NMR in Oncology: A Systematic Review.
Gómez-Cebrián N; (...); Pineda-Lucena A
Article. 10.3390/ph14101015. 2021
Pharmacotherapeutic management of advanced therapy medicinal products
Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia
Article. 10.7399/fh.13036. 2022
Phase II trial evaluating olaparib maintenance in patients with metastatic castration resistant prostate cancer (mCRPC) after docetaxel treatment, reaching partial or stable response: SOGUG-IMANOL study.
Juan Fita, Maria Jose; (...); Heras, Lucia
Meeting Abstract. 2023
Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study.
Juan Fita, Maria Jose; (...); Angel Climent, Miguel
Article. 10.3390/cancers15215223. 2023
Phase II trial of durvalumab plus tremelimumab with concurrent radiotherapy (RT) in patients (pts) with localized muscle invasive bladder cancer (MIBC) treated with a selective bladder preservation approach: IMMUNOPRESERVE-SOGUG trial.
Garcia del Muro, Xavier; (...); Vigues, Francesc
Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.4505. 2021
Phase II Trial of SBRT and Androgen Deprivation for Oligometastases in Prostate Cancer
Conde-Moreno, A. J.; (...); Albiach, C. F.
Meeting Abstract. 2021
Phase II Trial of SBRT and Androgen Deprivation for Oligometastases in Prostate Cancer.
Conde-Moreno AJ; (...); Albiach CF
Article. 10.1016/j.ijrobp.2021.07.151. 2021
Posterior Lingual Abscess; Report of Two Cases.
Saro-Buendia, Miguel; (...); Armengot Carceller, Miguel
Case Reports. 10.22037/aaem.v11i1.1860. 2023
Predictive Value of First Amniotic Sac IL-6 and Maternal Blood CRP for Emergency Cerclage Success in Twin Pregnancies.
Diago-Munoz, Diana Maria; (...); Diago-Almela, Vicente Jose
Article. 10.3390/jpm15010037. 2025
Preparation and administration of insulin infusions in neonatology: A national survey.
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Article. 10.1016/j.anpede.2020.06.015. 2021
Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Poveda Andrés JL, Edo Solsona MD
Article. 10.1016/j.farma.2023.06.0131130. 2024
Presenilin-1 Mutations Are a Cause of Primary Lateral Sclerosis-Like Syndrome
Vazquez-Costa, JF; (...); SEVILLA, T
Article. 10.3389/fnmol.2021.721047. 2021
Prognostic role of geriatric assessment (GA) in patients with metastatic prostate cancer (MPCaP) attended in medical oncology.
Girones, Regina, Arnal, Maria, Forcano, Silvia
Meeting Abstract. 2023
Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism.
Cosenza-Contreras, Miguel; (...); Schilling, Oliver
Article. 10.1093/neuonc/noad208. 2023
Radiological evaluation of the postsurgical middle ear.
Mazon, M.; (...); Carreres-Polo, J.
Article. 10.1016/j.rx.2021.04.005. 2021
Radiological evaluation of the postsurgical middle ear.
Mazón M; (...); Carreres-Polo J
Article. 10.1016/j.rxeng.2021.04.006. 2021
Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis
Rades, D; (...); Cacicedo, J
Article. 10.1186/s13063-020-04307-0. 2020
Real-world clinical practice patterns and outcomes for advanced ovarian cancer in Spain (GEICO-42-R study)
Redondo, Andres; (...); Gonzalez-Martin, Antonio
Article. 10.31083/j.ejgo4206163. 2021
Real-world evidence analysis of early-stage prostate cancer using natural language processing
Juarez, Alvaro; (...); Alcaraz, Antonio
Meeting Abstract. 2023
Recommended procedures and responsibilities for radiosurgery (SRS) and extracranial stereotactic body radiotherapy (SBRT): report of the SEOR in collaboration with the SEFM.
Conde-Moreno AJ; (...); Contreras Martínez J
Article. 10.1007/s12094-020-02540-2. 2021
Reduced incidence of neurologic complications after allogeneic hematopoietic stem cell transplantation with calcineurin-free graft-versus-host disease prophylaxis.
Balaguer-Rosello, Aitana; (...); Sanz, Jaime
Article. 10.1016/j.jtct.2023.07.008. 2023
Re-irradiation in NSCLC High-dose RT: Control, Survival and Toxicity
Germain, J.; (...); Conde, A.
Meeting Abstract. 2023
Role of the nigrosome 1 absence as a biomarker in amyotrophic lateral sclerosis
Isabel Moreno-Gambin, Maria; (...); Vázquez-Costa JF
Article. 10.1007/s00415-021-10729-w. 2021
RT after Encorafenib and Binimetinib on BRAF mutated melanoma brain metastases. GEM1802-Phase II
Alvarez, A.; (...); Marquez Rodas, I.
Meeting Abstract. 2023
Safety and efficacy of glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
Vaz, Maria Angeles; (...); Martinez-Garcia, Maria
Meeting Abstract. 2022
Salvage I-125 brachytherapy for locally-recurrent prostate cancer after radiotherapy
Pons-Llanas O; (...); López-Torrecilla J
Article. 10.1016/j.rpor.2020.06.010. 2020
Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM)
Ost, Piet; (...); Moon, Daniel
Meeting Abstract. 2024
SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021).
Martínez-García M; (...); Manuel Sepúlveda-Sánchez J
Article. 10.1007/s12094-022-02803-0. 2022
SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022).
Segura, Pedro Perez; (...); Losada, Estela Pineda
Article. 10.1007/s12094-023-03245-y. 2023
SEOR SBRT-SG survey on SRS/SBRT dose prescription criteria in Spain.
Perez-Calatayud MJ; (...); Perez-Calatayud J
Article. 10.1007/s12094-021-02583-z. 2021
SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis.
Lopez-Campos, F.; (...); Conde-Moreno, A.
Article. 10.1007/s12094-021-02695-6. 2022
SIOG COVID-19 Working Group recommendations on COVID-19 therapeutic approaches in older adults with cancer.
Russo, Chiara; (...); Battisti NML
Article. 10.1016/j.jgo.2023.101564. 2023
Small cone vs microMLC in SRS trigeminal neuralgia: Dosimetric improvement
Perez Calatayud, M. J.; (...); Tormo, A.
Meeting Abstract. 2020
SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization
Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis
Article. 10.1111/jcpt.13703. 2022
SOGUG-AVELUMAB_RWD: Comprehensive analysis of real-word data to evaluate the effectiveness and safety of avelumab maintenance therapy in patients with stage IV urothelial carcinoma conducted in Spain.
Juan Fita, Maria Jose; (...); Molina Diaz, Aurea
Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.e1656. 2024
Spinocerebellar Ataxia 36 is a Frequent Cause of Hereditary Ataxia in Eastern Spain
Baviera-Munoz, Raquel; (...); Bataller, Luis
Article. 10.1002/mdc3.13740. 2023
State of the scientific evidence and recommendations for the management of older patients with gastric cancer.
Paredero-Perez, Irene; (...); Girones-Sarrio, Regina
Article. 10.1016/j.jgo.2023.101657. 2023
Strategies to enhance management of HER2-positive breast cancer in the elderly: an expert consensus perspective.
Del Barco, Sonia; (...); Servitja, Sonia
Article. 10.1007/s12094-024-03838-1. 2025
STUB1 Mutations as Possible Genetic Modifiers in Spinocerebellar Ataxia Type 8.
Baviera-Munoz, Raquel; (...); Aller, Elena
Article. 10.1002/mds.29910. 2024
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
Megías-Vericat JE; (...); Montesinos P
Review. 10.3390/pharmaceutics14040878. 2022
The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity
Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar
Article. 10.1007/s00431-022-04628-z. 2022
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
Gil-Nagel A; (...); Gil A
Article. 10.1016/j.yebeh.2022.108711. 2022
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.
Zilli T; (...); Ost P
Editorial Material. 10.1016/j.euf.2020.12.010. 2021
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Badia, Xavier; (...); Valles, Joan-Antoni
Article. 10.1186/s13023-024-03324-5. 2024
Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies.
Guasp, Mar; (...); Graus, Francesc
Article. 10.1212/NXI.0000000000001053. 2021
To the editor, response letter.
Conde-Moreno AJ; (...); Contreras J
Letter. 10.1007/s12094-021-02641-6. 2021
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.
Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis
Article. 10.1136/ejhpharm-2024-004184. 2024
Treatment Landscape of Nonmetastatic Castration-Resistant Prostate Cancer: A Window of Opportunity.
López-Campos F; (...); Hervás Morón A
Article. 10.3390/jpm11111190. 2021
Uncovering a novel population of proliferative cells defined by the expression of BCAS1 in glioblastoma
Morales-Gallel, R.; (...); Garcia-Verdugo, J. M.
Meeting Abstract. 2023
Update on the management of elderly patients with colorectal cancer.
Soler-Gonzalez, Gemma; (...); Girones-Sarrio, Regina
Article. 10.1007/s12094-023-03243-0. 2023
Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology.
Guillot Morales M; (...); Gironés Sarrió R
Article. 10.1007/s12094-024-03386-8. 2024
Updated SIOG COVID-19 working group recommendations on COVID-19 vaccination among older adults with cancer.
Soto-Perez-de-Celis, Enrique; (...); Battisti, Nicolo Matteo Luca
Article. 10.1016/j.jgo.2022.07.005. 2022
VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA
Poveda, J. L.; (...); Lizan, L.
Meeting Abstract. 2023